Fusion protein to target and treat acute myeloid leukemia cells

COMBINATION THERAPY COMPRISING OX40 BINDING AGONISTS AND TIGIT INHIBITORS

Anti-CSFR1 antibody and anti PD-1 antibody combination therapy for cancer

Methods for producing subtypes of humanized antibody against interleukin-6 receptor

Inducible expression system

Antigen binding proteins capable of binding thymic stromal lymphopoietin

Pan-ELR CXC chemokine antibodies

Anti-NGF antibodies and methods using same

ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE TOXINS AND USES THEREOF

Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases

FCRN-BINDING ABOLISHED ANTI-IGF-1R ANTIBODIES AND THEIR USE IN THE TREATMENT OF VASCULAR EYE DISEASES

Animal Models and Therapeutic Molecules

Diagnostic assays and kits for detection of folate receptor 1

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

Human antigen binding proteins that bind β-klotho, FGF receptors and complexes thereof

Antibodies against CD73

Human anti-B7RP1 neutralizing antibodies

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

BISPECIFIC-FC MOLECULES

Human monoclonal antibodies specific for CD22

Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease

Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof

Cannabinoid receptor-1 (CB1) monoclonal antibodies

IL-21 binding proteins

Modified Variable Domain Molecules And Methods For Producing And Using Same

Angiopoietin-like 4 antibodies and methods of use

Antibodies against chikungunya virus and uses thereof

Pyrrolobenzodiazepines and conjugates thereof

Development of masked therapeutic antibodies to limit off-target effects

Anti-ErbB3 antibodies and uses thereof

Combination therapy using c-Met inhibitor and IGF-1R inhibitor for c-Met inhibitor resistant cancers

NOVEL ASSAY

Methods for controlling fucosylation levels in proteins

Amino acid sequence presenting fusion polypeptide and its use

Compositions and methods related to antibodies to staphylococcal protein A

Humanized anti-OX40 antibodies and uses thereof

Oncostatin M receptor antigen binding proteins

Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies

Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor

Antibody drug conjugates

Anti CD37 antibodies

Antibody specifically binding to insulin-like growth factor-1

Single domain binding molecule

Monoclonal antibodies that react with the capsule of

Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use

FcRn-specific human antibody and composition for treatment of autoimmune diseases

Antibody-drug conjugate having improved stability and use thereof

Glycoengineered antibody drug conjugates

Construction of diverse synthetic peptide and polypeptide libraries

Antigen binding protein and its use as addressing product for the treatment of cancer

Antibodies to ticagrelor and methods of use

ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA

ANTI-FACTOR VIII ANTIBODIES OR USES THEREOF

HER2/neu-specific antibodies and methods of using same

HER2-specific monoclonal antibodies and conjugates thereof

Glycan-interacting compounds and methods of use

Anti-IL-6/IL-6R antibodies

ANTI-CXCL9, ANTI-CXCL10, ANTI-CXCL11, ANTI-CXCL13, ANTI-CXCR3 AND ANTI-CXCR5 AGENTS FOR INHIBITION OF INFLAMMATION

Fc-free antibodies comprising two fab-fragments and methods of use

Methods of treating cancer with antibodies that bind P2X7 receptors

DOSING REGIMENS USING ANTI-IL-6 ANTIBODIES FOR THE TREATMENT OF RHEUMATOID AND PSORIATIC ARTHRITIS

Antibody neutralizers of human granulocyte macrophage colony stimulating factor

Anti-nodal antibodies and methods of using same

Methods for treating sepsis using chimeric and humanized anti-histone antibodies

Compositions and methods related to recombinant antibodies to histone posttranslational modifications

CMV neutralizing antigen binding proteins

Interferon lambda-antibody complexes

Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof

Monospecific and bispecific anti-IGF-1R and anti-ERBB3 antibodies

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

Anti-PDGFR-beta antibodies and uses thereof

Anti-HER2 single domain antibodies, polypeptides comprising thereof and their use for treating cancer

Anti-CS1 antibodies and antibody drug conjugates

Anti-TNF-/anti-IL-23 bispecific antibodies

Single domain antibodies directed against STAT3

Single domain antibodies against SOD1 and their use in medicine

Single domain antibodies directed against KRAS

Anti-CD38 human antibodies and uses thereof

CD20 Antibodies and Uses Thereof

Monoclonal antibody directed against CXCR5

Anti-GPIIB/IIIA antibodies or uses thereof

Targeting agent antibody conjugates and uses thereof

Antagonists of IL-6 to prevent or treat thrombosis

Single domain antibodies directed against TNF-alpha

Methods and compositions for treatment of Pompe disease

Anti-CEACAM5 antibodies and uses thereof

RSPO3 binding agents and uses thereof

Cytotoxic benzodiazepine derivatives

Antibodies that bind to Jagged 1

Antibody molecules to PD-L1 and uses thereof

Anti-ROBO4 antibody

Anti-TNF-α/CXCL10 double-targeting antibody and use thereof

Anti-CXCL1, CXCL7 and CXCL8 antibodies and their applications

Anti-C5 antibodies having improved pharmacokinetics

Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use

Compositions and methods for treatment and detection of cancers

Plasma kallikrein binding proteins

ANTI-LGR5 ANTIBODIES AND IMMUNOCONJUGATES

Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever

Antibodies targeting M-CSF

Single-domain VH antibodies directed to norovirus GI.1 and GII.4 and their use

Heteromultimers with reduced or silenced effector function

Therapeutic antibodies against ROR-1 protein and methods for use of same

Humanization of rabbit antibodies using a universal antibody framework

ANTI-CD38 HUMAN ANTIBODIES AND USES THEREOF

PC33718E

ANTIBODIES TO INSULIN-LIKE GROWTH FACTOR I RECEPTOR

Anti-HER2 antibodies and immunoconjugates

Folate receptor 1 antibodies and immunoconjugates and uses thereof

Folate receptor 1 antibodies and immunoconjugates and uses thereof

ANTIBODIES DIRECTED AGAINST AMYLOID-BETA PEPTIDE AND METHODS USING SAME

Neutralizing molecules to influenza viruses

Means and methods for producing high affinity antibodies

Polypeptide, anti-VEGF antibody, and anti-c-Met/anti-VEGF bispecific antibodies comprising the same

Construction and application of bispecific antibody EpCAM×CD3

Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity

ANTI-CRTH2 ANTIBODIES AND METHODS OF USE

NOVEL ANTIBODIES

Binding proteins specific for insulin-like growth factors and uses thereof

Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof

Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy

Anti-CCL2 and anti-LOXL2 combination therapy for treatment of scleroderma

Fusion proteins and immunoconjugates and uses thereof which are specific for glycophorin A

Bispecific HER2 and HER3 antigen binding constructs

CD3 and IL-23 receptor binding bispecific constructs and their use in the treatment of various diseases

Folate receptor 1 antibodies and immunoconjugates and uses thereof

Anti-Ghrelin Antibodies and Uses Thereof

Anti-IL-25 antibodies and uses thereof

Methods of treatment using anti-GDF15 antibodies

Antigen associated with the neovasculature of tumour metastases

Antiviral agent against animal viruses

Cytotoxic benzodiazepine derivatives

Isoform specific anti-HER4 antibodies

Antibodies to Carcinoembryonic Antigen (CEA), Methods of Making Same, and Uses Thereof

Antibody polypeptides that antagonize CD40L

Anti-ectodysplasin antibodies

Anti-CLL-1 antibodies and immunoconjugates

Bispecific T cell activating antigen binding molecules

Antibodies directed against programmed death-1 (PD-1)

Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

Folate receptor 1 antibodies and immunoconjugates and uses thereof

Anti-DLL3 antibodies

Anti-glucagon antibodies

Anti-serum albumin binding variants

MONOCLONAL ANTIBODIES AGAINST THE RGM A PROTEIN FOR USE IN THE TREATMENT OF RETINAL NERVE FIBER LAYER DEGENERATION

Anti-wall teichoic antibodies and conjugates

Immunity inducer for saccharide antigens

SELECTION OF FAB FRAGMENTS USING RIBOSOMAL DISPLAY TECHNOLOGY

Methods for affinity maturation-based antibody optimization

FC-RECEPTOR BINDING MODIFIED ASYMMETRIC ANTIBODIES AND METHODS OF USE

Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B

Monoclonal antibody recognizing sialylated sugar chains

CD123 binding agents and uses thereof

Anti-DR5 antibodies, polynucleotides and methods

Isolation of therapeutic target specific VNAR domains to ICOSL

Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms

Monoclonal antibody against necrosis marker PRDX4 and use thereof

Anti-C5 antibodies and methods of treating complement-related diseases

Antibodies against toxins and methods of using the same

PD-1 antibodies

Interleukin-10 Compositions and Uses Thereof

Human antibody drug conjugates against tissue factor

Anti-FAP antibodies and methods of use

Anti-FAP antibodies and methods of use

Site-specific glycoengineering of targeting moieties

ANTI-HER2 ANTIBODY VARIANTS

ANTIBODIES TARGETING SPECIFICALLY HUMAN CXCR2

Anti-FOLR1 antibody

Folate receptor 1 antibodies and immunoconjugates and uses thereof

Compound targeting IL-23A and TNF-alpha and uses thereof

Therapeutic DLL4 binding proteins

PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGENIC DISEASE

POLYPEPTIDE VARIANTS WITH ALTERED EFFECTOR FUNCTION

Anti-infective binding proteins that bind AIP2

Antibody therapeutics that bind OprF

METHODS FOR FORMULATING ANTIBODY DRUG CONJUGATE COMPOSITIONS

Anti-c-Met/anti-Ang2 bispecific antibody

METHODS OF TREATMENT FOR NEUROMYELITIS OPTICA

Antibodies against human RYK and uses therefor

Human antibodies against tissue factor and methods of use thereof

Anti-human TROP-2 antibody having anti-tumor activity in vivo

Anti-CD276 polypeptides, proteins, and chimeric antigen receptors

Antibodies to a non-ligand binding region of at least two NOTCH receptors

Nucleic acids encoding antibodies against human CSF-1R

Fully human anti-CXC chemokine receptor 5 (CXCR5) antibodies

Fully human anti-C-X-C chemokine receptor 3 (CXCR5) antibodies

Melatonin monoclonal antibody, detection, methods and uses thereof

Nucleic acids encoding anti-C5a antibodies

Methods of inhibiting complement C4 activation with anti-complement C1s antibodies

Uses of antibodies directed against amyloid-β

Methods of treating retinal disorders with anti-apelin antibodies

FUNCTIONAL HEAVY CHAIN ANTIBODIES, FRAGMENTS THEREOF, LIBRARY THEREOF AND METHODS OF PRODUCTION THEREOF

Composition comprising at least two influenza A virus-neutralizing-binding molecules

Method for isolation of soluble polypeptides

DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF

IDENTIFICATION AND MOLECULAR CHARACTERISATION OF PROTEINS, EXPRESSED IN THE IXODES RICINUS SALIVARY GLANDS

SPECIFIC BINDING PROTEINS AND USES THEREOF

Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor

Antibodies that bind LGR4, their use in inhibiting neoplastic cells and in treating tumors

Antibodies and methods for treating estrogen receptor-associated diseases

Antibodies that bind colony stimulating factor 1 receptor (CSF1R)

Therapeutic peptides

Anti-CDH6 antibody drug conjugates

Neutralizing anti-CCL20 antibodies

Heterodimeric immunoglobulins

Antibody molecules to dengue virus and uses thereof

Antigen-Binding Molecule for Promoting Disappearance of Antigen via Fc gamma RIIB

Antibodies to MICA and MICB proteins

Antibody constructs for influenza M2 and CD3

Methods for producing fabs and bi-specific antibodies

Human CD30 ligand antigen binding proteins

Human PAC1 antibodies

CD3 binding domains

Methods for treating IL-6 mediated diseases with antibody molecules specific for IL-6

Anti-IL-17A antibodies and their use in treating autoimmune and inflammatory

Transthyretin antibodies and uses thereof

HUMANIZED ANTIBODIES SPECIFIC FOR STAPHYLOCOCCAL ENTEROTOXIN B

HUMAN ANTIGEN BINDING PROTEINS THAT BIND TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9

Method of reducing blood glucose by administering RON agonists

Antibodies capable of specifically binding two epitopes on tissue factor pathway inhibitor

HER3 specific monoclonal antibodies for diagnostic and therapeutic use

High affinity anti-GD2 antibodies

Human Antibody Fragments Against Chondroitin Sulfate Proteoglycan 4 (CSPG4)

Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity

Anti-RANKL antibodies and methods of use

Fibronectin III domain of IL-11Rα

ANTIBODIES AGAINST G-CSFR AND USES THEREOF

IL3Rα antibody conjugates and uses thereof

COMPOSITIONS AND METHODS FOR INCREASING MUSCLE GROWTH

Anti-alpha V beta 6 antibodies and uses thereof

Therapeutic DLL4 binding proteins

CHARGE-ENGINEERED ANTIBODIES OR COMPOSITIONS OF PENETRATION-ENHANCED TARGETING PROTEINS AND METHODS OF USE

Compositions and methods for growth factor modulation

Tau immunotherapy

Compositions and Methods for Antibodies Targeting Complement Protein C5

Method of treatment with antibodies having specificity for human OX40

Radio-labelled antibody fragments for use in the prevention and/or treatment of cancer

cKIT antibody drug conjugates

Formulation of human antibodies for treating TNF-α associated disorders

Biomarker Hsp90 for predicting effect of a c-Met inhibitor

Proteins specific for BAFF and B7RP1 and uses thereof

Anti-CD52 antibodies

LLT-1 antibodies with new functional properties

Method of imaging a cardiovascular disease with an anti-macrophage mannose receptor immunoglobulin single variable domain

Anti-H7CR antibodies

Antigen binding constructs to CD8

Human antibodies to NA1.7

Monoclonal antibodies targeting EpCAM for detection of prostate cancer lymph node metastases

Human antibody specific for interleukin-1alpha

HUMAN MONOCLONAL ANTIBODIES THAT NEUTRALIZE BIOACTIVITY OF GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR AND METHODS AND USES THEREOF

Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II

CONNECTIVE TISSUE GROWTH FACTOR ANTIBODIES

ANTIBODIES AGAINST AMYLOID-BETA PEPTIDE

Secreted frizzle-related protein 5 (SFRP5) binding proteins

Human antibodies to GREM1

Compositions and methods for treating angiogenesis-related disorders

Anti-tau antibodies and methods of use

Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof

METHOD FOR AFFINITY PURIFICATION

Fucosidase from bacteroides and methods using the same

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases

Single linker FabFv antibodies and methods of producing same

ANTI-PLASMA KALLIKREIN ANTIBODIES

Non-Antagonistic EGFR-Binding Molecules and Immunoconjugates Thereof

Anti-factor D antibodies

Precision medicine for cholesterol treatment

CD20-binding immunotoxins for inducing cellular internalization and methods using same

Antibody fragments, compositions and uses thereof

Anti-B7-H4 antibodies and immunoconjugates

Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof

Anti-LAG-3 binding proteins

Anti-hepcidin antibodies and uses thereof

Engineered anti-TGF-beta antibodies and antigen-binding fragments

Methods and compositions with immune therapy for treatment of dementia

Tridentate connexon and use thereof

ANTI-CD22 ANTIBODY-DRUG CONJUGATES AND METHODS OF USING THEREOF

Anti-DLL3 antibody drug conjugates

M-CSF specific monoclonal antibody and uses therof

Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent

Monoclonal antibody, inhibiting the enzymatic activity of vascular endothelial lipase

Anti-TFPI Antibody Variants with Differential Binding Across pH Range For Improved Pharmacokinetics

PRO-DRUG ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR

Endoglin antibodies

Specific binding antibodies of glycoprotein IB alpha as selective ectodomain shedding inhibitors

Modulators

Polynucleotides encoding human oncostatin M antibodies

Methods and compositions for targeting polyubiquitin

Neutralizing antibodies to HIV-1 and their use

Monoclonal antibodies that neutralize a norovirus

Methods for achieving therapeutically effective doses of anti-CD47 agents for treating cancer

Detection of free and protein-bound non-human gal-alpha(1-3)-gal epitope

Coiled coil and/or tether containing protein complexes and uses thereof

Compositions for inhibiting MASP-2 dependent complement activation

Anti-factor Bb antibodies

Anti-RSPO2 antibodies and uses thereof

ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF

Anti-HER3 antibodies binding to the beta-hairpin of HER3

Therapeutic use of anti-CS1 antibodies

Anti-ASIC1 Antibodies and Uses Thereof

ANTI-NOTCH1 ANTIBODIES